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SUMMARY
The sequelae of Infectious Intestinal Disease (IID) in a population-based sample of cases
and matched controls were investigated for a period of 3 months following the initial infection.
Incident cases of IID presenting to GPs or occurring in the community and controls were studied
at 3 weeks and over a 3-month follow-up period. Cases were six times more likely than controls
to have gastrointestinal symptoms, particularly diarrhoea, at 3 weeks. Ten per cent of cases
consulted their GP in the 3 months after episode and 2.3% were referred to hospital. GP
presentation rates were twice as high in cases. Gastrointestinal symptoms persist after IID,
leading to an increased likelihood of GP consultation and hospital referral. Diagnosis of irritable
bowel syndrome may be more likely following IID. The burden of IID is likely to be considerable
given its high incidence and the frequency of such sequelae.
INTRODUCTION
Food poisoning and infectious intestinal disease (IID)
are important diseases in the United Kingdom [1].
Food poisoning notiﬁcations and laboratory reports
of pathogens responsible for IID have been falling
in the last 4 years. However, in 2001 there were over
85000 food poisoning notiﬁcations and 1 in 60 people
consulted a GP for IID [2, 3] in England and Wales.
This represents a considerable burden of disease.
Bacterial gastroenteritis may not be a short self-
limiting illness, but instead may have longer term
consequences [4]. Several conditions have been speciﬁ-
cally associated with prior bacterial gastroenteritis,
such as reactive arthritis (RA), irritable bowel syn-
drome (IBS), Guillain–Barre syndrome (GBS) and
haemolytic uraemic syndrome (HUS) [4–7]. Although
relatively uncommon, such conditions cause a con-
siderable burden of ill health. There have been no
population-based studies described which aim to
ascertain the full range of sequelae of all types of
IID. The national IID study was a population-based
study in England which assessed the frequency of
IID in the community and presenting to GPs. It had
a case control component to assess factors associated
with new IID. This paper presents the ﬁndings of a
3-month prospective follow-up of IID cases and their
controls. Most of the cases would not have reached
routine surveillance systems, so the ﬁndings in this
paper are unique in that they include cases of IID who
are not routinely detected by health services.
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The Study of IID in England was based in 70 volun-
teer GP practices throughout England from the
Medical Research Council’s General Practice Re-
search Framework. The study population was rep-
resentative of general practices in England in terms
of geographical region, urban and rural mix, and
socio-demographic characteristics [8]. Approval was
obtained from the Royal College of General Prac-
titioners, participating research bodies, and all local
research ethics committees. The methods have been
fully described elsewhere [9]. Cases were ascertained
either presenting to the general practice clinic (in 34
practices) or arising within a community cohort of an
average of 135 individuals selected at random from
each of 70 practices.
The case deﬁnition of IID was: loose stools or sig-
niﬁcant vomiting lasting less than 2 weeks, in the ab-
sence of a known non-infectious cause and preceded
by a symptom-free period of 3 weeks [9]. For each
case an age-sex matched control was selected at ran-
dom from the GP list or from within the community
cohort. Both cases and controls were followed up
prospectively for 3 months after the case episode.
Information was collected on clinical symptoms
using postal questionnaires; at case onset and at 3
weeks. In children under 16 years, the questionnaire
was ﬁlled by the parent or guardian. Self assessment
of symptom severity in cases at onset were graded as
mild, moderate or severe. The symptoms related to
the gastrointestinal, musculo-skeletal, neurological.
GP case notes were searched 3 months after incident
IID by the research nurse in each practice to record all
symptoms, diagnoses, and hospital referrals in the
preceding 10-week period (excluding the 2 weeks after
the onset of IID) on a standardized proforma. Read
codes were used to classify the reason for the GP
consultation. The Read code is a hierarchical coding
system. Whenever possible the disease code was used
in preference to a symptom code, treatment code or
referral code [10]. If a patient had been referred to
hospital for gastrointestinal, neurological, renal or
rheumatological problems, letters were sent to the
referral consultant requesting details. Consequences
of speciﬁc interest were RA, IBS, GBS and HUS.
Information on potential gastrointestinal patho-
gens detected in stools of cases and controls from the
IID study was available, but not for the follow-up
period. Inclusion of subjects in this component was
dependent on receiving informed written consent to
access clinical notes. 2.5% of cases and 4.5% of
controls were excluded at this stage.
Statistical methods
The representativeness of subjects giving consent
compared to the total cases and controls sample with
respect to age, sex and Jarman score was investigated
using multiple logistic regression. Symptoms were
compared between cases and controls in three age
groups: 0–4 years (infants and young children), 5–15
years (older children) and 16 years and over (adults).
Symptoms persisting at 3 weeks and their severity
were compared to those at the onset of illness. Per-
sistent symptoms were assessed as rates of GP pres-
entation and hospital referral rates per week over
the 3 months post episode. Presentation rates were
analysed using random eﬀects Poisson regression to
account for patient level clustering. The follow-up
period was divided into two time intervals, 2–3 weeks
and 4–12 weeks, after the initial IID episode. For the
controls the relevant time period was taken from the
time of the matched case IID episode. GP consul-
tationsin the3-months periodprior tothe IID episode
were studied in a sub-sample of subjects. Compari-
sons of GP consultation rates per week in cases and
controls by diagnosis and age (<16 years and o16
years) are reported as odds ratios.
RESULTS
Recruitment of cases and controls
In the general practice case-control component 30
practices of 34 in the IID general practice presen-
tation study and 55 of 70 in the IID study community
component took part in the present study. A total of
1441 (40%) cases and 1448 (56%) controls gave
consent for a note search in the general practice case-
control component. In the community case-control
component compliance was higher: 458 (63%) and
385 (60%) respectively. A note search was carried out
on 96% of those giving consent. There was no diﬀer-
ence in either component in the compliance of cases
by age and sex although there was a tendency for
cases in higher Jarman score practices (more de-
prived), to be less likely than controls to give consent
for a note search.
For the 3 month follow-up there were note searches
for 1413 cases and 1377 controls in the general prac-
tice case-control component and 442 cases and 373
controls in the community case-control component.
454 P. Cumberland and othersA total of 111 hospital letters about cases and 69
about controls were received, 78 and 66% of those
requested, respectively. Matched cases numbering 508
in the general practice case-control component and
255 in the community case-control component com-
pleted questionnaires gave information on symptoms
at 3 weeks.
Frequency of reactive arthritis, irritable
bowel syndrome, Guillain–Barre syndrome and
haemolytic uraemic syndrome
There were no cases diagnosed with or referrals for
RA, GBS or HUS in the 3-month period of follow up.
In the note search at 3 months, adults were more
likely to have musculo-skeletal complaints than the
controls but the diﬀerence was not statistically sig-
niﬁcant. Among hospital referrals, cases from general
practice were not more likely than controls to be re-
ferred for musculo-skeletal symptoms (Table 1).
Gastrointestinal symptoms 3 weeks after onset of IID
In all age groups, the cases were more likely than con-
trols to have gastrointestinal symptoms at 3 weeks:
diarrhoea, vomiting, abdominal pain, loss of appetite
and loss of weight (Table 2). Overall 24% of cases
with diarrhoea at onset of IID reported persistent
diarrhoea 3 weeks after onset. The proportion was
highest in children aged 0–2 years, 28% (24–31%),
and in adults increased from 15% to 29% relative
to severity at onset. Thirteen per cent (12–15%) of
cases with vomiting and 28% (27–30%) of those with
abdominal pain at onset had persistent symptoms at
3 weeks. There was no consistent pattern with any
other symptoms.
Three-month follow up: GP presentation rates from
all causes
A total of 1413 cases in the general practice case-
control component and 440 cases in the community
case-controlcomponentwerefollowedupfor12weeks
after initial case episode. In the general practice
component 12.3% of cases presented each week in the
2–3 weeks after the initial episode compared to 6.4%
of controls. A total of 9.4% of cases presented per
week at 4–12 weeks after episode compared to 6.0%
of controls. These weekly rates in cases and controls,
if extrapolated, are equivalent to 4.9a n d3 .1 consul-
tations per person per year. The rates increased with
Jarman score in cases whereas they were higher with
low and high Jarman score in controls (Table 3). The
presentation rates in cases in the community compo-
nent were lower, 8.7% at 2–3 weeks and 7.0% at 4–12
weeks.
Young children and adults were more likely to
present to the GP than older children. Females were
more likely to present than males after adjustment
for age in the general practice case-control RR 1.21
(1.09–1.35), with no eﬀect of Jarman score. In both
study components cases were signiﬁcantly more likely
to present to the GP (for all causes) than contorls,
both at 2–3 weeks and 4–12 weeks after IID episode,
Table 1. GP presentation and hospital referral, 2–12 weeks after case IID episode, by diagnosis and age
GP case-control component
Hospital referral
Case Control Case Control OR (95% CI) P value
Musculoskeletal disease
Child 597 611 0 1
Adult 815 753 11 7 1.46 (0.51–4.46) 0.484
Gastrointestinal disease
Child 597 611 10 4 2.59 (0.74–11.35) 0.113
Adult 815 753 23 5 4.34 (1.60–14.69) 0.002
Other
Child 597 611 25 16 1.63 (0.82–3.29) 0.153
Adult 815 753 50 42 1.11 (0.71–1.73) 0.668
No diagnoses or symptoms coded
Child 597 611 6 7 0.85 (0.24–2.98) 0.789
Adult 815 753 8 11 0.67 (0.23–1.84) 0.490
Symptoms and health care after IID 455even after adjustment for sex, age and Jarman score
(Table 4). There was no evidence of interaction with
sex or age.
There was information on prior presentation in 831
(57%) of cases and 548 (40%) of controls. The ad-
justed rate ratios in this subset were lower, RR=1.55
(1.24–1.82) (P<0.001) at 2–3 weeks and RR=1.16
(1.05–1.29) (P=0.005) at 4–12 weeks. After ad-
ditional adjustment for prior presentation to the GP,
the rate ratios were reduced but still signiﬁcant,
RR=1.48 (1.22–1.81) (P<0.001) at 2–3 weeks and
RR=1.13 (1.02–1.25) (P=0.021) at 4–12 weeks, in
the general practice case-control component.
Three-month follow up: GP presentation by
symptom type
Adult cases were three times more likely and children
two times more likely than controls to present to their
GP with gastrointestinal complaints 4 to 12 weeks
after the episode (Table 5).
The diagnosis in consultations for most children
was presumed infectious diarrhoea and gastroenter-
itis, whereas in adults the diagnoses were more evenly
distributed among presumed infectious diarrhoea,
IBS and gastroenteritis. In the general practice case-
control component 21 cases of 815 cases (2.6%) and
Symptom
GII
Diarrhoea
Blood in stool
Vomiting
Abdominal pain
Loss of appetite
Loss of weight
Flatulence
Discomfort
passing urine
Case
(n = 172)
n
45
02
20
18
38
15
12
07
Control
(n = 172)
n
10
01
08
09
23
03
07
06
OR
5·74
2·01
2·70
2·12
1·84
5·38
1·77
1·17
(95% CI)
(2·8–11·8)
(0·18–22·13)
(1·18–6·17)
(0·94–4·76)
(1·05–3·23)
(1·63–17.6)
(0·70–4.47)
(0·40–3·40)
Case
(n = 48)
n
09
00
08
13
06
03
04
00
Control
(n = 48)
n
02
00
01
07
02
01
01
01
OR
5·59
9·4
2·18
3·29
3·13
4·27
(95% CI)
(1·14–27·49)
(1·13–78.41)
(0·80–5.90)
(0·63–17·18)
(0·31–31.25)
(0·50–39·72)
Case
(n = 288)
n
82
11
20
88
60
53
64
09
Control
(n = 288)
n
17
09
06
35
10
07
41
08
OR
6·34
1·23
3·51
3·18
7·32
9·05
1·72
1·13
(95% CI)
(3·67–10.97)
(0·52–2·94)
(1·43–8·61)
(2·07–4·90)
(3·70–14·44)
(4·11–19·89)
(1·12–2·65)
(0·44–2·88)
0–4 years 5–15 years >16 years
P values: <0·001 0·001–0·04 0·05–0·1
Table 2. Symptoms in matched cases and controls 3 weeks after case episode, by age
Table 3. GP presentation rates (per 100 people per week)
GP case-control component
Cases Controls
2–3 weeks 4–12 weeks 2–3 weeks 4–12 weeks
n Rate (95% CI) Rate (95% CI) n Rate (95% CI) Rate (95% CI)
Age (years)*
0–4 473 14.3 (12.2–16.8) 11.2 (10.2–12.2) 481 8.2( 6 .6–8.3) 7.4( 6 .6–8.3)
5–15 124 10.1( 7 .0–14.8) 6.0( 4 .7–7.6) 130 1.4( 0 .5–3.8) 4.0( 3 .0–5.3)
16+ 815 11.5 (10.0–13.2) 8.8( 8 .1–9.5) 753 5.9( 4 .9–7.3) 5.4( 4 .9–6.0)
Sex
Male 671 11.7 (10.0–13.6) 8.4( 7 .7–9.2) 612 6.6( 5 .4–8.2) 5.4( 4 .8–6.1)
Female 742 12.9 (11.2–14.8) 10.2( 9 .5–11.0) 764 6.2( 5 .1–7.5) 6.5( 5 .9–7.1)
Jarman score
Low 232 10.5( 8 .0–13.7) 9.0( 7 .8–10.4) 212 9.0( 6 .6–12.3) 6.2( 5 .1–7.4)
Mid 817 11.8( 9 .2–14.4) 10.3( 8 .7–11.1) 850 5.3( 4 .3–6.4) 5.8( 5 .3–6.4)
High 364 14.6 (12.2–17.6) 9.4( 8 .4–10.5) 315 7.6( 5 .7–9.9) 6.4( 5 .5–7.4)
Total 1413 12.3 (11.1–13.6) 9.4( 8 .8–9.9) 1377 6.4( 5 .5–7.4) 6.0( 5 .6–6.5)
* Missing age data: 1 case, 13 controls.
456 P. Cumberland and others3 of 753 controls (0.4%) were recorded as having IBS.
Five cases diagnosed with IBS had campylobacter
infection but this was not a statistically signiﬁcantly
high proportion compared to all cases. No cases had
known salmonella infection. More cases than controls
presented to the GP with abdominal pain. There were
no cases of Crohn’s disease though two GPs diag-
nosed cases of idiopathic proctocolitis and ulcerative
enterocolitis.
Three-month follow up: hospital referral
In the general practice component cases were more
likely than controls to be referred to hospital for
gastrointestinal disease in adults P<0.001 (Table 1).
This association was not statistically signiﬁcant for
children. Two adult cases, diagnosed by their GP as
having diarrhoea of presumed infective origin, were
diagnosed at hospital as having IBS. Three of the
Musculoskeletal
Child
Adult
Case
n
2–3 weeks after case IID episode
P values: <0·001 0·001–0·04 0·05–0·1
Table 5. GP presentation by diagnosis, by age
597
815
Control
n
611
753
Case
n
00
09
Control
n
00
06
OR
1.39
(95% CI)
(0·51–3·77)
P value
0·53
Gastrointestinal disease
Child
Adult
597
815
611
753
15
36
06
01
2·60
34·75
(1·03–6·53)
(4.75–254)
0·04
<0·001
Other
Child
Adult
597
815
611
753
74
67
47
60
1·70
1·03
(1·16–2·49)
(0·72–1·49)
0·007
0·85
No diagnoses or symptoms coded
Child
Adult
597
815
611
753
514
723
558
687
0·59
0·75
(0·41–1·05)
(0·54–1·05)
0·004
0·10
Case
n
01
30
Control
n
2
23
OR
0·51
1·21
(95% CI)
(0·05–5·65)
(0·70–2·09)
P value
0·58
0·49
36
52
19
16
2·00
3·14
(1·14–3·50)
(1·79–5·51)
0·015
<0·001
150
166
144
135
1·09
1·17
(0·84–1·42)
(0·91–1·51)
0·53
0·22
429
608
452
595
0·90
0·78
(0·70–1·16)
(0·62–0·99)
0·41
0·04
4–12 weeks after case IID episode
GP case control component
Table 4. GP presentation rates
GP case-control component
Univariate Adjusted
Factor Rate ratio (95% CI) P value Rate ratio (95% CI) P value
Case: Control (weeks)
2–4 1.93 (1.60–2.33) <0.001 1.98 (1.64–2.39) <0.001
4–12 1.56 (1.39–1.75) <0.001 1.57 (1.40–1.76) <0.001
Sex (female) 1.15 (1.04–1.28) 0.009 1.21 (1.09–1.35) <0.001
Age (years)*
0–4 1.88 (1.52–2.34) <0.001 1.92 (1.55–2.38) <0.001
5–15 1.00 1.00
16+ 1.46 (1.18–1.81) <0.001 1.41 (1.14–1.74) 0.001
Jarman score
Low 1.00
Mid 0.96 (0.83–1.12) 0.631
High 1.07 (0.90–1.27) 0.421
* Baseline, age group 5–15 years.
Symptoms and health care after IID 457four children with a diagnosis of gastroenteritis of
presumed infectious origin had this conﬁrmed on
hospital referral.
DISCUSSION
Main ﬁndings
Cases of IID were one and a half times more likely to
consult their GP with gastrointestinal symptoms over
a period of 3 months after the intial IID episode, were
more than four times as likely to be referred to hos-
pital and six times as likely to receive a diagnosis of
IBS. Our ﬁndings show that after IID gastrointestinal
symptoms persist in more patients than is commonly
acknowledged [11]. Almost a quarter of all cases had
persistent diarrhoea 3 weeks after the onset of the
incident illness, over an eighth had persistent vomit-
ing and nearly a third of older children and adults
had abdominal pain. The persistence of diarrhoea in
cases 3 weeks after onset resulted in a rate sixfold
higher than in controls. A tenth of patients who had
had IID sought repeat consultation (for all causes)
with their GPs over 3 months follow-up. Though this
fell with time there was a more than 50% increase in
presentation compared to controls. This had not been
previously described in a cohort of cases with IID.
Whilst it was partly explained by whether patients had
previously consulted their GP, thus reﬂecting health
seeking behaviour, it remained a statistically signiﬁ-
cant and clinically important independent risk factor
after adjustment for prior presentation.
Cases were more likely to consult their GP than
controls if they were either children under 5 years old,
adults over 60, or of female sex. Increased health ser-
vice use has been previously described in females
when compared to males [12] and in the extremes of
age [13]. This suggests that once ill with IID, GP
consultation is higher in these groups because of
health seeking behaviour, but it also increased with
greater severity of illness. It is not known whether
consultations related to initial, repeat or new infec-
tions. In this study there was no association between
practice Jarman score and repeat consultation for
IID. Others have described higher GP consultation
rates in association with area deprivation [14, 15].
Controls were age- and sex-matched, so were not
fully representative of the population. However, esti-
mates from weekly presentation rates in controls, if
extrapolated to annual rates, give a rate of more than
three consultations per year per patient. Fleming
estimated the ﬁgure to be 3.5 consultations per year
per patient [16].
The reasons for the increase in cases seeking repeat
consultation with their GP was examined. Our ap-
proach was hierarchical, in keeping with the Read
classiﬁcation system [10]. This approach revealed that
there was an increased risk of the cases re-consulting
their GP with a gastrointestinal complaint, overall a
tenth of cases, and the illness was severe enough to
warrant hospital referral in 2.3% of cases. There was
a fourfold increase in risk for hospital referral in
adults. In adults, at a more speciﬁc level of analysis,
the risk of seeking repeat consultation with their GP
speciﬁcally for diarrhoea and gastroenteritis were
about 28-fold and there was a sixfold increase in risk
for the diagnostic label IBS.
Comparison with other studies
Few studies have followed up cases of community
acquired IID. Neal et al. [4] showed that the preva-
lence of altered bowel habit in cases of bacterial gas-
troenteritis was 25% at 6 months. This supports our
ﬁnding of self-reported persistent gastrointestinal
symptoms during the shorter follow up period of
3 weeks. The prevalence of IBS following IID in our
study was 2.8%. In contrast the prevalence of IBS
following bacterial gastroenteritis has been reported
as higher at 4.4 and 7.0% where the follow up was
6 months [4, 17]. This could be explained by the fact
that our case deﬁnition was based on clinical criteria
as opposed to being bacteriologically conﬁrmed. It is
likely that cases in those two studies were more severe
as they had stools sent for testing as part of the clini-
cal consultation, and only those that were positive
were included. We have previously shown that only
22% of cases presenting to GPs with IID had stools
sent for routine testing, often among the more severe
cases. An even smaller proportion of cases in the
community have stools sent for testing [1, 18].
We found rates of IBS of 25.8 and 4 per 1000
in cases and controls respectively. This compares to
estimates of incidence ranging from 3.5 per 1000 per-
son years in a general practice cohort population to
39.7 per 1000 person years in a cohort with bacterial
gastroenteritis [17]. The same authors found a relative
risk of 12 after bacterial gastroenteritis. Our result
may reﬂect a case mix that included milder cases
and the study design which depended on clinically
diagnosed cases identiﬁed from case notes, rather
than more sensitive and speciﬁc methods such as
458 P. Cumberland and othersquestionnaires with criteria speciﬁc for IBS. Whilst it
is possible that cases in our study with pre-existing
IBS might have been misclassiﬁed as having IID at
presentation this is unlikely as our case deﬁnition ex-
cluded cases with pre-existing chronic diarrhoea [9].
Our study however raises the possibility that IBS may
develop after infection with infectious agents of un-
known origin and may also be a complication of cases
with less severe IID. Campylobacter and salmonella
have been identiﬁed as causative organisms in the
development of IBS [4, 19]. In our study only ﬁve of
our cases who developed IBS, had campylobacter
isolated. None had salmonella isolated.
In the study by Neal et al. [4] only 5% of those with
bacterial gastroenteritis sought care from their GP
regarding symptoms of altered bowel habit. Our study
found a higher presentation rate of 10.3% for gas-
trointestinal symptoms by 3 months. This diﬀerence
could be explained by the fact that we used note
searches, whereas Neal et al. [4] used a questionnaire
administered at 6 months, which may have led to
under-ascertainment.
The strength of our study was the prospective
follow-up of unselected incident cases of IID that
included cases in a community cohort and those pre-
senting to their GP. The design of the study was based
upon the assumption that it would be possible to re-
cruit cases and their controls for long-term follow-up.
The response rate by subjects was lower than ex-
pected. However, comparison between those recruited
and those who were not, indicates there was no stat-
istically signiﬁcant diﬀerence in terms of age and sex.
There was a tendency for refusal for consent to be
higher in practices in more deprived areas, which may
have led to an underestimate of absolute presentation
rates, as GP consultation is higher in more deprived
areas [15]. We had no standardized assessment to
ascertain cases with sequelae, but used data from GP
case notes and examination of copies of hospital let-
ters which might have lead to misclassiﬁcation and
most likely under ascertainment of sequelae.
There were small numbers of cases for each organ-
ism. This decreased the power of the study to test
speciﬁc associations. For example, reports from out-
breaks suggest that the prevalence of reactive arthritis
following bacterial gastroenteritis is 2–3%, but this
is highest following yersinia infection [20]. The GP
morbidity study in 1995 [21] described a rate of reac-
tive arthritis of 13.7 per 100000 person years. We
found no increase in suggestive symptoms of RA or
cases of RA but we had very few cases (n=26) with
yersinia infection so our study lacked power. This is
also true for rarer outcomes such as GBS which has
an estimated national incidence of 1 per 100000 per
year [22]. Another limitation was the relatively short
duration of follow up. In GBS only 70% of cases
appeared at 12 weeks after infection [23] and cases of
IBS and RA have been described several months after
bacterial gastroenteritis [4].
Implications of our study
IID causes considerable burden of ill health, over and
above the initial event, requiring a considerable pro-
portion of cases to seek repeat consultation with the
GP within 3 months of illness, some of whom required
referral to hospital. Such eﬀects are not conﬁned to
bacterial gastroenteritis. There are health service
costs associated with these, as well as broader socio-
economic costs. The ﬁndings suggest that IBS could
be triggered by prior IID or possibly some of our cases
were really manifestations of IBS and not IID. This
could be further investigated by following up a large
number of notiﬁed cases of campylobacter infection
or other speciﬁc organisms. Standardized ascertain-
ment of cases of IBS, using clear diagnostic criteria
should be used. Another approach, to identify other
possible agents that may act as a trigger for IBS, may
be to use a network of Sentinel general practices with
the routine linkage of surveillance data. Ascertained
cases of IBS could be linked retrospectively to cases of
IID, thus broadening the knowledge base of causative
organisms and long-term sequelae.
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